These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 2444889)

  • 41. The conserved N-terminus of human rhinovirus capsid protein VP4 contains membrane pore-forming activity and is a target for neutralizing antibodies.
    Panjwani A; Asfor AS; Tuthill TJ
    J Gen Virol; 2016 Dec; 97(12):3238-3242. PubMed ID: 27902347
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The Tecumseh study of respiratory illness. IV. Prevalence of rhinovirus serotypes, 1966-1969.
    Monto AS; Cavallaro JJ
    Am J Epidemiol; 1972 Nov; 96(5):352-60. PubMed ID: 4344343
    [No Abstract]   [Full Text] [Related]  

  • 43. Cross relationships among 37 rhinoviruses demonstrated by virus neutralization with potent monotypic rabbit antisera.
    Cooney MK; Kenny GE; Tam R; Fox JP
    Infect Immun; 1973 Mar; 7(3):335-40. PubMed ID: 4351585
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Antibodies that block rhinovirus attachment map to domain 1 of the major group receptor.
    Lineberger DW; Graham DJ; Tomassini JE; Colonno RJ
    J Virol; 1990 Jun; 64(6):2582-7. PubMed ID: 1970837
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Characterization of two newly recognized rhinovirus serotypes of human origin.
    Kapikian AZ; Mufson MA; James HD; Kalica AR; Bloom HH; Chanock RM
    Proc Soc Exp Biol Med; 1966; 122(4):1155-62. PubMed ID: 4288216
    [No Abstract]   [Full Text] [Related]  

  • 46. The major and minor group receptor families contain all but one human rhinovirus serotype.
    Uncapher CR; DeWitt CM; Colonno RJ
    Virology; 1991 Feb; 180(2):814-7. PubMed ID: 1846502
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Possible defense against common cold: 'block that cellular receptor site'.
    Marwick C
    JAMA; 1986 Aug 22-29; 256(8):967-8, 970-1. PubMed ID: 3016354
    [No Abstract]   [Full Text] [Related]  

  • 48. Picornaviruses: epitopes, canyons, and pockets.
    Smith TJ; Baker T
    Adv Virus Res; 1999; 52():1-23. PubMed ID: 10384234
    [No Abstract]   [Full Text] [Related]  

  • 49. Protective effect of rhinovirus receptor blocking antibody in human fibroblast cells.
    Sperber SJ; Hayden FG
    Antiviral Res; 1989 Dec; 12(5-6):231-8. PubMed ID: 2561332
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Virus versus antibody.
    Colman PM
    Structure; 1997 May; 5(5):591-3. PubMed ID: 9235220
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Evidence for protective effect of an inactivated rhinovirus vaccine administered by the nasal route.
    Perkins JC; Tucker DN; Knope HL; Wenzel RP; Hornick RB; Kapikian AZ; Chanock RM
    Am J Epidemiol; 1969 Oct; 90(4):319-26. PubMed ID: 4309899
    [No Abstract]   [Full Text] [Related]  

  • 52. Microneutralization test for detection of rhinovirus antibodies.
    Monto AS; Bryan ER
    Proc Soc Exp Biol Med; 1974 Feb; 145(2):690-4. PubMed ID: 4360649
    [No Abstract]   [Full Text] [Related]  

  • 53. Editorial Note: Cross-Serotype Immunity Induced by Immunization with a Conserved Rhinovirus Capsid Protein.
    PLOS Pathogens Editors
    PLoS Pathog; 2024 May; 20(5):e1012213. PubMed ID: 38710011
    [No Abstract]   [Full Text] [Related]  

  • 54. Micro-neutralization test for identification of rhinovirus serotypes.
    Gwaltney JM
    Proc Soc Exp Biol Med; 1966; 122(4):1137-41. PubMed ID: 4288213
    [No Abstract]   [Full Text] [Related]  

  • 55. Structural studies on antibody recognition and neutralization of viruses.
    Smith TJ
    Curr Opin Virol; 2011 Aug; 1(2):150-6. PubMed ID: 21887208
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Characterization of human rhinoviruses displaced by an anti-receptor monoclonal antibody.
    Abraham G; Colonno RJ
    J Virol; 1988 Jul; 62(7):2300-6. PubMed ID: 2836613
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Developing Strategies to Treat Asthma Exacerbations Caused by Rhinovirus.
    Heymann PW
    EBioMedicine; 2015 Jan; 2(1):11-2. PubMed ID: 26137528
    [No Abstract]   [Full Text] [Related]  

  • 58. Rhinovirus infections in an industrial population. V. Change in distribution of serotypes.
    Calhoun AM; Jordan WS; Gwaltney JM
    Am J Epidemiol; 1974 Jan; 99(1):58-64. PubMed ID: 4359510
    [No Abstract]   [Full Text] [Related]  

  • 59. Antibody to rhinovirus in human sera. I. Standardization of a neutralization test.
    Douglas RG; Fleet WF; Cate TR; Couch RB
    Proc Soc Exp Biol Med; 1968 Feb; 127(2):497-502. PubMed ID: 4296290
    [No Abstract]   [Full Text] [Related]  

  • 60. Serotypic relationships among rhinoviruses.
    Fenters JD; Gillum SS; Holper JC; Marquis GS
    Am J Epidemiol; 1966 Jul; 84(1):10-20. PubMed ID: 4287641
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.